These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22946841)

  • 21. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.
    Yotsuyanagi H; Shintani Y; Moriya K; Fujie H; Tsutsumi T; Kato T; Nishioka K; Takayama T; Makuuchi M; Iino S; Kimura S; Koike K
    J Infect Dis; 2000 Jun; 181(6):1920-8. PubMed ID: 10837171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
    Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
    Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
    Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
    Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis C virus RNA in tumor tissues of Chinese liver cancer patients].
    Zhang CX; Lu YP; Yu ZY
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):673-5, 709. PubMed ID: 7866902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of β-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Alam El-Din HM; Morsy HM; Shaarawy S; Moharram NZ; Daoud SS
    Oncol Rep; 2011 Oct; 26(4):825-31. PubMed ID: 21701780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.
    Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Takahashi I; Chayama K
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):846-54. PubMed ID: 18398026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
    Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
    Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
    Wang W; Zhao LJ; Wang Y; Tao QY; Feitelson MA; Zhao P; Ren H; Qi ZT
    Cancer Biomark; 2011-2012; 11(1):29-39. PubMed ID: 22820138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.